a few weeks ago, shares in gw pharma lost a third of their value after uk regulators said they wanted more evidence about the drug's benefits.but now canadian authorities have said the sativex drug will be considered for approval.now, gw pharma's sativex mouth spray could be legally available to ms sufferers in canada within the next few months.this will be the first time a cannabis based drug has been approved anywhere in the world, representing a landmark for gw pharma and for patients with ms.we are delighted to receive this qualifying notice from health canada and look forward to receiving regulatory approval for sativex in canada in the early part of 2005, said gw pharma executive chairman dr geoffrey guy.despite hopes of regulatory approval last year, a series of delays has put back sativex's launch in the uk.